ELIZABETH DUFFY: Open Payments
NPI 1871045351 · THOMASVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 24 payments from 11 companies in 2025. Trend: 2023 $558 · 2024 $584 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $241 |
| Merck Sharp & Dohme LLC | 4 | $73 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Pharmacosmos Therapeutics Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $40 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $23 |
Products named: CAMZYOS, REBLOZYL, VERQUVO, OJJAARA, NINLARO, MONOFERRIC, LEQVIO, JARDIANCE.
Industry payments across NC — which companies pay providers there.
